Eli Lilly Stock News & Updates

[WKN: 858560 | Symbol: LLY]

Analysts' Top 5 Price Targets of May 22, 2026

Eli Lilly [US5324571083] Wolfe Research confirms Outperform rating with a price target of 1350 USD...

Analysts' Top 5 Price Targets of May 5, 2026

Pinterest [US72352L1061] TD Cowen reaffirms Buy rating and adjusts target price from $36 to $38 (57%...

Eli Lilly (LLY) – The pharmaceutical giant ignites new growth surge with weight-loss medications and significantly raises annual forecast!

Eli Lilly delivers a quarter to marvel at: Revenue +56% to $19.8 billion, EPS at $8.55 far exceeds expectations....

Multiple Billion-Dollar Deals and Medical Revolution! Eli Lilly Takes the Next Growth Stage with Foundayo!

The US pharmaceutical giant Eli Lilly (LLY) is once again making significant moves in the acquisition...

Eli Lilly: Strong Growth, Strategically Smart and Attractive After Setbacks!

The stock of Eli Lilly (NYSE: LLY) remains, in my view, a high-quality growth asset with an attractive...

Eli Lilly: 2 Billion USD for the Future of Cancer Medicine!

Eli Lilly (NYSE: LLY) is on the verge of acquiring Kelonia Therapeutics for over 2 billion USD. A remarkable...

Diabetes Boom: These Stocks Will Benefit from the $190 Billion Market!

The global market for obesity and diabetes therapies is undergoing a structural reassessment: Investment...

Eli Lilly: Foundayo is Cementing Market Leadership in the Obesity Sector

The market for obesity treatments is currently experiencing a fundamental shift, and Eli Lilly is positioning...